Li Zhu Medicine (01513.HK) spent 4.9987 million yuan on September 19 to repurchase 127,200 A-shares.

CapitalWatch App News: Luye Pharma Group Ltd (01513.HK) announced that on September 19, 2025, the company plans to repurchase 127,200 A-shares at a total cost of RMB 4,998,700. The repurchase price is set between RMB 39.08 and 39.63 per share.